- Home
- SXTC vs ALIS Comparison
SXTC vs ALIS Comparison
Compare SXTC & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.99
Company Overview
Basic Information| Metric | SXTC | ALIS |
|---|---|---|
| Founded | 2005 | 2024 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.9M | 85.6M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | SXTC | ALIS |
|---|---|---|
| Price | $1.99 | $10.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 42.2K | 31.1K |
| Earning Date | 08-19-2019 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $9.87 |
| 52 Week High | $6.98 | $10.25 |
Technical Indicators
Market Signals| Indicator | SXTC | ALIS |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 56.58 |
| Support Level | $1.95 | $10.05 |
| Resistance Level | $2.21 | N/A |
| Average True Range (ATR) | 0.32 | 0.04 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 27.36 | 27.27 |
Price Performance
Historical Comparison SXTC
ALIS
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About ALIS Calisa Acquisition Corp Ordinary shares
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.